Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 14 professional analysts, the 12-month price target for Ionis Pharmaceuticals stock ranges from a low of $39 to a high of $77. The average analyst price target of $58.43 forecasts a 35.57% increase in the stock price over the next year.

Price Target: $58.43 (+35.57%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$39	$58.43	$62	$77
Change	-9.51%	+35.57%	+43.85%	+78.65%

Analyst Ratings

The average analyst rating for Ionis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	6	7	7	7	5	5
Buy	6	4	4	4	5	5
Hold	6	6	6	5	3	4
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	0
Total	19	18	18	17	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Esther Rajavelu UBS	UBS	Hold Maintains $45 → $46	Hold	Maintains	$45 → $46	+6.73%	Aug 12, 2025
Gary Nachman Raymond James	Raymond James	Strong Buy Maintains $60 → $64	Strong Buy	Maintains	$60 → $64	+48.49%	Jul 31, 2025
Michael Ulz Morgan Stanley	Morgan Stanley	Hold → Buy Upgrades $55 → $62	Hold → Buy	Upgrades	$55 → $62	+43.85%	Jul 31, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $50 → $65	Strong Buy	Maintains	$50 → $65	+50.81%	Jul 31, 2025
Gena Wang Barclays	Barclays	Hold → Buy Upgrades $51 → $57	Hold → Buy	Upgrades	$51 → $57	+32.25%	Jul 1, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

770.05M

Increased by 9.21%

from 705.14M

Revenue Next Year

880.57M

Increased by 14.35%

from 770.05M

EPS This Year

-3.15

from -3.04

EPS Next Year

-3.22

from -3.15

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	729.26M	810.46M	587.37M	787.65M	705.14M	770.05M	880.57M	1.20B
Revenue Growth	-35.04%	11.13%	-27.53%	34.10%	-10.48%	9.21%	14.35%	36.62%
EPS	-3.18	-0.20	-1.90	-2.56	-3.04	-3.15	-3.22	-1.63
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	29	29	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	952.4M	1.4B	1.6B
Avg	770.1M	880.6M	1.2B
Low	701.0M	608.6M	395.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	35.1%	76.5%	84.3%
Avg	9.2%	14.4%	36.6%
Low	-0.6%	-21.0%	-55.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-2.43	-1.47	-0.13
Avg	-3.15	-3.22	-1.63
Low	-3.88	-4.82	-3.37

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.